JPRN-UMIN000007656
Completed
未知
Hiroshima NT-proBNP study in hemodialysis patients (HINT) - NT-proBNP in hemodialysis patients
Department of Nephrology, Hiroshima University Hospital0 sites1,000 target enrollmentStarted: April 3, 2012Last updated:
Conditionsend stage renal failure
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- Department of Nephrology, Hiroshima University Hospital
- Enrollment
- 1,000
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients who are younger than 20 years old, peritoneal dialysis patients, do not undergo hemodialysis three times a week, have a poor prognosis cancer, have a severe infectious disease, and show symptoms of heart failure at rest
Investigators
Similar Trials
Recruiting
Not Applicable
Kyusyu Prospective Cohort Study in Hemodialysis PatientsChronic hemodialysis patientsJPRN-UMIN000033365ARO Next Generation Medical Center3,600
Completed
Phase 4
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal diseaseISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2006-003650-20-ITMerck and Co Inc.276
Active, not recruiting
Phase 1
A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis BEUCTR2006-003650-20-GBMerck & Co Inc.,276
Completed
Not Applicable
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40